Endo UV Tech Submits Audited Financial Statements for Fiscal Years 2021 and 2022
Oakland Park, Florida - June 19, 2023 - Photothrombotics, Inc. (doing business as Endo UV Tech), a leading innovator in UV technologies, has officially completed its audited financial statements for the fiscal years 2021 and 2022. This action underscores the company's commitment to transparency and compliance with financial regulations.
The company's financial statements were audited by the reputable Friedman CPA Group, in accordance with auditing standards generally accepted in the United States of America. The auditors provided a fair and objective examination of the company's financial operations.
Friedman CPA Group's independent audit concluded that the financial statements of Endo UV Tech fairly represent the company's financial position for the years ended December 31, 2022 and 2021. It confirmed the reliability of our statements of operations, changes in members’ deficit, and cash flows for the periods reviewed, in line with generally accepted accounting principles.
The independent auditors' report has neither modified the conclusion nor included any adjustments that might result from the uncertainties stated above. The audit process also encompassed an in-depth review of our internal controls, accounting policies, and significant accounting estimates.
Endo UV Tech's management takes complete responsibility for the preparation and presentation of these financial statements. We have maintained a rigorous internal control system that aims to prevent and identify any material misstatements due to fraud or error.
The audit reports are available for public review, underscoring our commitment to transparency and adhering to the highest standards of corporate governance.
About Endo UV Tech
Endo UV Tech is at the forefront of UV laser technology innovation, primarily applied in the medical field for the effective removal of blood clots in the brain and heart. Our advanced technology works in synergy with stentrievers and aspiration devices, furnishing surgeons with the state-of-the-art tools necessary for achieving the most successful patient outcomes.
The revolutionary potential of our UV laser technology has been recognized through numerous global patents, a testament to our unique and critical contribution to the medical field. With more than two decades dedicated to the exploration, research, and rigorous testing of this groundbreaking treatment modality, our expert team remains committed to continual advancement and refinement in order to set new standards in patient care.
For more information, please visit www.endouvtech.com.
Contact
For media inquiries:
Chip Van Vurstchip@endouvtech.com
Cautionary Statement
This press release contains forward-looking statements that involve risks, uncertainties, and assumptions. If any of these risks or uncertainties materializes or any of these assumptions proves incorrect, the results of Endo UV Tech could differ materially from those expressed or implied by these forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to any projections of financial performance; statements of the plans, strategies, and objectives of management for future operations; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. Endo UV Tech assumes no obligation and does not intend to update these forward-looking statements.